Biomarkers in diabetes: analytical and clinical...
Transcript of Biomarkers in diabetes: analytical and clinical...
Biomarkers indiabetes:analytical and clinical perspectives
February 23 - 24, 2017 · Hotel Crowne Plaza · Belgrade, Serbia
U N D E R T H EA U S P I C E S O F
PROGRAMMEU N D E R T H E A U S P I C E S O F
ORGANIZERS
Clinical Center of Serbia,Center for Medical Biochemistry andClinic for Endocrinology, Diabetes and Metabolic Disorders
COORGANIZERS
Serbian Diabetes Society
Board on Cardiovascular Pathology of theSerbian Academy of Sciences and Arts
AUSPIECES
2nd Serbian Biomarkers SymposiumBiomarkers in diabetes: analytical and clinical perspectivesis organized under the auspices of
International Federation of Clinical Chemistryand Laboratory Medicine (IFCC)
European Federation of Clinical Chemistryand Laboratory Medicine (EFLM)
European Society of Pharmacogenomicsand Personalised Therapy (ESPT)
Ministry of Health of the Republic of Serbia
Ministry of Education, Science and Technological Development of Serbia
UNDER HONORARY PATRONAGE
TRH Crown Prince Alexander and Princess Katherine Karadjordjevic
Dear Colleagues and Friends,
It is a great pleasure and honor to invite you to the 2nd Serbian Biomarker
Symposium (SERBIS) that will be held in Belgrade, Serbia, on February 23-24, 2017.
This international symposium is arranged to bridge clinical and laboratory work,
emphasizing the importance of teamwork and interactions between all
professionals involved in the �ght against diabetes mellitus and personalized
medicine approach. The 2nd SERBIS with the overall theme Biomarkers in diabetes:
analytical and clinical perspectives is intended to display the state of the biomarker
use at the interface between diabetes mellitus and laboratory medicine.
This symposium will bring together international experts who will provide a
comprehensive and up-to-date overview of recent advances in the �eld of
integrated biomarker assessment and quali�cation in the context of diagnosis,
treatment, and prevention of diabetes. Our innovative and original programme this
year promises to be challenging and stimulating as we consider key topics of
interest and concern, covering a range of topical and relevant issues which a�ect us
all from the laboratory to the clinic.
The most recent advances in the management of diabetes focusing on HbA1c and
new biomarkers will be presented, followed by pharmacogenomic �ndings which
will greatly improve the e�cacy of diabetes treatment.
We are convinced that SERBIS will be top level educational and scienti�c event in
our region, giving to the participants an excellent opportunity for education and
chance for improvement of personal achievements. It will o�er a unique
opportunity to identify new research ideas and establish collaboration with
colleagues from di�erent countries. Also, to keep up to date with Industry partners
who will showcase their latest advances on their booths in bio-technology
innovations, novel assays and therapies in diabetes �eld.
We hope that SERBIS will meet your expectations, provide you some unforgettable
personal and professional memories, and trust that you will enjoy your visit to the
very beautiful and exciting cosmopolitan city of Belgrade.
We look forward to welcoming you in Belgrade.
Sincerely yours,
Milika AsaninNebojsa M. LalicSanja Stankovic
HONORARY COMMITTEE
Asst. dr Zlatibor LoncarMinister of Health of the Republic of Serbia
Mladen SarcevicMinister of Education, Science and Technological Development of the Republic of Serbia
Academician Vladimir KosticPresident of Serbian Academy of Sciences and Arts
Academician Dragan MicicPresident of Serbian Health Council
Academician Vladimir KanjuhPresident, Board on Cardiovascular Pathology of the Serbian Academy of Sciences and Arts
Academician Ljubisa RakicPresident, Board on Biomedical Investigation of the Serbian Academy of Sciences and Arts
Academician Radoje ColovicPresident of Serbian Medical Association
Academician Vladimir BumbasirevicRector, University of Belgrade
Academician Jovan Hadzi-Dzokic
Academician Nebojsa LalicDean, University of Belgrade, School of Medicine
Prof. dr Zorica VujicDean, University of Belgrade, School of Pharmacy
SCIENTIFIC COMMITTEE
Milika AsaninAntonio Ceriello
Joris DelangheEmma English
Michèle FonfredePhilippe Gillery
Garry JohnAleksandra Jotic
Patricia KaiserVladimir Kanjuh
Eric KilpartickKatarina Lalic
Nebojša M. LalicPaivi Laitinen
Erna Lenters-Westra Randie Little Dragan Micic
Andrea MoscaDavid Sacks
Sverre SandbergRon van Schaik Petar Seferovic
Goran StankovicSanja Stankovic
Cas Weykamp
ORGANIZING COMMITTEE
Daniela BartolovicAndjelo BeleticEmina ColakAnica DjordjevicJelica DjordjevicRadica DunjicOlja GabricJasna IlicMirjana MilivojevicRadmila ObrenovicGordana StosicTatjana VodnikDragana Vukosavljevic
WEDNESDAY, FEBRUARY 22, 20172nd SERBIS ProgrammeBiomarkers in diabetes: analytical and clinical perspectives
15:00-16:15 Special Pre-Symposium Session
Chair: Sanja Stankovic
15.00-15.30 Antionio Ceriello (Italy)Markers of glycemic control
15:30-16:00 Nebojsa M.Lalic (Serbia)Individual treatment goals in diabetes: the role of biomarkers
16:00-16:15 Q&A (Discussion)
THURSDAY, FEBRUARY 23, 2017 08:30 - 10:00 Registration OPENING CEREMONY 10:00-10:30 Welcome note 10:30-11:00 Cocktail
THURSDAY, FEBRUARY 23, 2017Session 1
Chairs: Garry John, Nebojsa M. Lalic 11:00-11:30 Garry John (UK)A general history of HbA1c from 1960s to 2016
11:30-12:00 David Sacks (USA)HbA1c in diabetes and pre diabetes diagnosis
12:00-12:30 Nebojsa M. Lalic (Serbia)Diagnosis of diabetes: achievements and pitfalls
12:30-12:40 Q&A (Discussion) Chairs: Ron van Schaik, Sanja Stankovic 12:40-13:10 Ron van Schaik (The Netherlands) Pharmacogenetics in diabetes: where do we stand?
13:10-13:40 Sanja Stankovic (Serbia)Pharmacogenetics of metformin response:current evidence and future prospects
13:40-13:50 Q&A (Discussion) 13:50-14:50 Lunch
THURSDAY, FEBRUARY 23, 2017Session 2
Chairs: Sverre Sandberg, Eric Kilpatrick 14:50-15:20 Erna Lenters-Westra (The Netherlands)Standardization of HbA1c assays
15:20-15:50 Cas Weykamp (The Netherlands)Performance criteria of HbA1c assay devices
15:50-16:20 Sverre Sandberg (Norway)POCT of HbA1c: advantages and pitfalls
16:20-16:50 Emma English (UK)Which lessons from meta-analyses on HbA1c?
16:50-17:20 Eric Kilpatrick (Qatar)Clinical outcomes of HbA1c standardization
17:20-17:30 Q&A (Discussion)
FRIDAY, FEBRUARY 24, 2017Session 3
Chairs: Cas Weykamp, Andrea Mosca
10:00-10:30 Randie Little (USA)The NGSP experience of HbA1c
10:30-11:00 Patricia Kaiser (Germany)Challenges in HbA1c evaluation by LC/MS
11:00-11:30 Andrea Mosca (Italy)Impact of Hb variants and RBC disorders on HbA1c interpretation
11:30-11:40 Q&A (Discussion) 11:40-11:50 Co�e break
FRIDAY, FEBRUARY 24, 2017Session 4
Chairs: Philippe Gillery, Joris Delanghe 11:50-12:20 Fonfrede Michèle (France)Other markers or short-term glycation:fructosamine, glycated albumin, 1,5-anhydroglucitol
12:20-12:50 Philippe Gillery (France)Advanced glycation end products as biomarkers in diabetesmellitus and chronic diseases
12:50-13:20 Joris Delanghe (Belgium)Keratin glycation as a biomarker for diabetes
13:20-13:50 Aleksandra Jotic (Serbia)Diabetes in pregnancy: the relevance of standard markersof glucose control
13:50-14:00 Q&A (Discussion) 14:00-15:00 Lunch
FRIDAY, FEBRUARY 24, 2017Session 5
Chairs: Vladimir Kanjuh, Dragan Micic 15:00-15:30 Vladimir Kanjuh (Serbia)Causes, histopathology and consequences of vascularlesions in diabetes mellitus type 2 15:30-16:00 Dragan Micic (Serbia)Obesity, diabetes and cardiovascular risk markers
16:00-16:30 Katarina Lalic (Serbia)Lipid abnormalities in diabetes: LDL or nonHDL?
16:30-17:00 Petar Seferovic (Serbia)Metabolic factors in cardiac failure
17:00-17:30 Paivi Laitinen (Finland)Cardiac troponin and diabetes
17:30-18:00 Goran Stankovic (Serbia)Predictors of stent thrombosis
18:00-18:10 Q&A (Discussion) 18:10-18:40 Summary and closing of the symposium
Hotel Crowne Plaza
4 star hotel in Belgrade.
Hotel address: Vladimira Popovica 10 Street, 11 070 Belgrade, Serbia
Phone: +381 11 2204-115, fax: +381 11 2204-104
E-mail: [email protected]
Web: www.ihg.com
Registration is free of charge and includes:
- Participation in all lectures
- Course material
- Registration material
- Access to exhibition
- Certi�cate of attendance
- Welcome cocktail
- Everyday lunch in Crown Plaza Hotel
- Refreshments with drinks and snacks
LANGUAGEThe o�cial language of the Symposium is English.
CURRENCYThe Serbian currency is Serbian Dinar (abbreviated as RSD). Current exchange rate is
about 124 RSD for 1 Euro. Credit cards (VISA, Euro card, MasterCard, American
Express, Diners Club) are accepted in most shops. Automated Teller Machines
(ATMs) and Exchange o�ces are also available in the Hotel. For detailed information
contact Hotel reception.
PUBLIC TRANSPORTATIONBus lines 74, 88, 95, as well as tram lines 7, 7L, 9, 11, and 13 connect the Crowne
Plaza Hotel with the City. The free multiple use tickets can be acquired at
registration desk. Taxis are available throughout the City of Belgrade, and also in
front of the Crowne Plaza Hotel.
WEATHER FORCASTDuring the two days of the Symposium mostly cloudy weather is expected, and
daily temperatures ranging from 0-3°C (source: www.accuweather.com).
SCIENTIFIC SECRETARIATSanja Stankovic, Clinical Center of Serbia,
Address: Višegradska 26, 11000 Belgrade, Serbia.
Phone/Fax: +381-11-361-5631,
Mobile phone: +381-63-237449.
E-mail: [email protected]
TRAVEL AGENCYFor hotel reservations and travel arrangements please contact
Ms. Radmila Maricic - SMART TRAVEL PCO
Address: Njegoseva 72 a, 11000 Belgrade
Phone: (+ 381) 11 770 2184, (+ 381) 11 770 2522
Mobile phone: +381 63 25 20 24
Fax: (+ 381) 11 244 7524
Email: [email protected]
Web: www.smarttravelpco4.rs
Accommodation of the faculty members is organized at the Hotel Crowne
Plaza. Transportation from the airport and from the hotel will be organized
for all invited speakers.
WiFiFree WiFi is provided for al Symposium participants.
REGISTRATION DESKRegistration desk will be opened on Thursday February 23rd 2017, from 8:30 AM.
Registration fee for participants is free of charge. Preregistered participants can
pick up their name badges and Symposium material at the Registration desk
from Thursday February 23rd 2017, 8:30 AM. Symposium speaker’s abstracts will
be available at Symposium web site www.serbis.rs.
CERTIFICATES OF ATTENDANCEThe Symposium program is accredited by the Serbian Health Council with 10
CME credit hours for participants and 15 for lecturers (No. 153-02-3989/2016-01,
Ev. No. Ц-1-93/17). Certi�cates of attendance will be available at the Registration
Desk, on Friday, February 24, 2017 from 06:00 PM.
SYMPOSIUM WEBSITE:www.serbis.rs
P L A T I N U M S P O N S O R
SPONSORSPRINCIPAL SPONSOR